The weight loss process shows significant regional heterogeneity, especially with the highest relative reduction in central fat
Colombo F, Smith S, Lai GW, Nix D, Smith PG, Schindler J, et al
Appetite scores, rated on a 1 to 10 scale at consistent times of day, reveal whether your GLP-1 and GIP receptor activation is adequate
Always follow applicable regulations and guidelines in your jurisdiction
Patients often notice reduced shedding first, followed by gradual improvement in density over time
For many Canadians, starting with approved options like Tirzepatide or Semaglutide while monitoring Retatrutides regulatory progress makes practical sense